𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impaired insulin action in newly diagnosed type 1 (insulin-dependent) diabetes mellitus

✍ Scribed by A. Nankervis; J. Proietto; P. Aitken; F. Alford


Publisher
Springer
Year
1984
Tongue
English
Weight
771 KB
Volume
27
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

✦ Synopsis


Hepatic and peripheral insulin sensitivity were investigated in five newly diagnosed Type 1 (insulin-dependent) diabetic subjects before and after 1 week of twice daily insulin therapy. Eight weight-matched control subjects were also studied. Hepatic glucose production and glucose utilization were measured basally and during two sequential 2-h insulin (25 and 40 mU X kg-1 X h-1)/ glucose infusion periods. In the untreated hyperglycaemic diabetic patients hepatic glucose production was 16.3 +/- 2.6, 8.1 +/- 1.1 and 3.6 +/- 2.8 mumol X kg-1 X min-1 respectively for each of the three periods (mean +/- SEM), and fell with treatment to 12.5 +/- 1.4, 0.5 +/- 0.5 and 0.5 +/- 0.5 mumol X kg-1 X min-1. Hepatic glucose production for normal subjects was 13.4 +/- 0.7, 2.3 +/- 0.8 and less than 0.1 mumol X kg-1 X min-1. Glucose utilization was 12.7 +/- 1.4, 18.2 +/- 0.7 and 22.1 +/- 3.4 mumol X kg-1 X min-1 before treatment in the diabetic subjects, and 11.8 +/- 1.7, 20.9 +/- 3.3 and 30.1 +/- 3.6 after treatment. These values compare with those in the euglycaemic control subjects (13.4 +/- 0.7, 18.7 +/- 1.6 and 36.3 +/- 2.7 mumol X kg-1 X min-1). The pre-treatment metabolic clearance rate of glucose in all diabetic studies with insulin levels greater than 30 mU/l was 2.6 +/- 0.4 and rose to 3.9 +/- 0.5 ml X kg-1 X min-1 following insulin therapy.(ABSTRACT TRUNCATED AT 250 WORDS)


πŸ“œ SIMILAR VOLUMES


Immunoregulatory T-lymphocyte subset def
✍ A. Galluzzo; C. Giordano; G. Rubino; G. D. Bompiani πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 551 KB

Humoral and cell-mediated disorders in Type 1 (insulin-dependent) diabetes suggest that an imbalance of immunoregulatory T-cell subsets exists. In 23 newly diagnosed (onset less than 3 months) and 21 long-standing Type 1 diabetic patients, T lymphocyte subsets were analyzed using monoclonal antibodi

Cyclosporin A treatment of young childre
✍ M. Jenner; G. Bradish; C. Stiller; P. Atkison; The London Diabetes Study Group πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 629 KB

Several studies have demonstrated the efficacy of cyclosporin A in modifying the initial course of Type 1 (insulin-dependent) diabetes mellitus in older children and adults but none have reported the effects in very young children. We treated 14 newly-diagnosed Type 1 diabetic patients aged 22 month

Immunogenicity of monocomponent human an
✍ L. G. Heding; M. O. Marshall; B. Persson; G. Dahlquist; B. Thalme; F. Lindgren; πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 238 KB

The aim of the present study was to compare the immunogenicity of monocomponent human insulin with that of monocomponent porcine insulin in newly diagnosed Type 1 (insulin-dependent) diabetic children. One hundred and thirty-five patients at diagnosis of diabetes (age 1-18 years, mean age 9.3 years)

Remissions in newly diagnosed Type 1 (in
✍ V. A. Koivisto; A. Aro; K. Cantell; M. Haataja; J. Huttunen; S. -L. Karonen; P. πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 492 KB

We studied the effect of interferon as an adjunct to conventional insulin therapy on the early course of Type 1 diabetes in 43 newly diagnosed patients. Compared with conventional therapy, interferon administration slightly delayed the improvement of glucose homeostasis and the rise of high density